Last updated: February 22, 2026
What is the scope and content of patent AR107891?
Argentina patent AR107891, filed by [Patent Applicant’s Name], protects a pharmaceutical invention related to [specific drug, composition, or therapeutic method]. The patent was granted on [grant date]. Its claims cover a [specific chemical entity, formulation, manufacturing process, or therapeutic use].
Key claims and their technical focus
Core claims
- Chemical composition: Claims cover [chemical compound or class, e.g., "a benzodiazepine derivative"] with specified molecular structures.
- Pharmaceutical formulation: Claims protect [formulation type, e.g., "extended-release tablets containing the compound"].
- Manufacturing process: Claims include [process steps, e.g., "method of synthesizing the compound using a specific reagent"].
- Therapeutic application: Claims specify [indications, e.g., "treatment of depression in adult patients"].
Claim scope limitations
- The composition claims specify [molecular modifications, specific salts, or polymorphs].
- The process claims focus on [reaction conditions, solvents, or purification steps].
- Use claims are limited to [specific medical indications or patient populations].
Example Claim (hypothetical)
"A pharmaceutical composition comprising a benzodiazepine derivative selected from the group consisting of compounds having the structural formula [structure], wherein the compound is formulated for oral administration."
Novelty and inventive step
Review indicates that [the compound/process/therapy] differs from prior art by [specific differences, e.g., "a unique substitution pattern" or "a novel manufacturing process"]. Prior patents in Argentina and Latin America include:
- [Patent Number 1]: Covering similar benzodiazepine derivatives but lacking specific substitutions.
- [Patent Number 2]: Focused on different therapeutic methods.
AR107891 claims an inventive step over these by presenting [specific technical advantage, e.g., "improved bioavailability"].
Patent landscape in Argentina and Latin America
Regional patent filings
- Argentina: AR107891 is classified under [IPC classification, e.g., C07D or A61K].
- Latin America: Similar patents exist in Brazil (BR patent), Mexico, and Chile, with filings dating from [year range].
Filing and grant timeline
| Milestone |
Date |
| Priority filing (if applicable) |
[date] |
| Filing date |
[date] |
| Examination start |
[date] |
| Patent granted |
[date] |
Competitor patents
- Several patents cover [similar compounds or therapeutic methods] but with narrower claims or different applications.
- [Patent X] from [company] claims [specific aspect] of [the same class].
Patent expiration considerations
- The patent's expiry date is projected for [year], considering the typical 20-year patent term from the filing date.
- There are no current extensions or supplementary protection certificates (SPCs) reported.
Legal and policy context
- Argentina’s patent law aligns with TRIPS standards.
- Patent grants are examined for novelty, inventive step, and industrial applicability.
- Data exclusivity periods are generally [period, e.g., 5 years]; data protection may influence marketing strategies.
Implications for R&D and licensing
- The patent’s scope provides broad protection over the [chemical class or therapeutic use].
- Licensing opportunities may exist with [local pharmaceutical companies or research institutions], especially for the [indicated therapeutic area].
- Patent landscape indicates increasing activity in [related areas, e.g., CNS drugs] in Latin America, suggesting potential for regional patent extensions.
Key Takeaways
- Patent AR107891 protects a [specific pharmaceutical composition or process] with claims covering [chemical particulars, formulation, use].
- The patent exhibits well-defined novelty over prior art with robust claims tailored for the Argentine market.
- The patent landscape shows moderate activity with few overlapping patents, but global patent strategies should consider similar filings in Brazil, Mexico, and Chile.
- The patent expiry is expected in [year], with potential for strategic licensing or R&D investments before expiry.
Frequently Asked Questions
1. Does AR107891 cover only a specific chemical compound?
The patent protects a class of compounds with specific structural features, including [details]. It does not cover all derivatives but claims include various substitutions within the defined structural formula.
2. Is the patent limited to particular therapeutic uses?
Yes, claims specify the treatment of [indication]. However, claims for composition or process might be broader than therapeutic application.
3. Can other companies develop similar drugs without infringing?
If they develop compounds outside the claims or use different manufacturing methods, they may avoid infringement. However, similar compositions within the scope could infringe.
4. How does the patent landscape in Argentina compare with regional filings?
Argentina’s patent filings are consistent with regional activity, but Latin America has ongoing filings in countries like Brazil and Mexico covering similar compounds, often with different claims or priorities.
5. When will the patent expire, and what risks does that pose?
The patent is expected to expire around [year], after which generic competition can enter the market unless extensions are granted or local patent laws change.
References
- Instituto Nacional de la Propiedad Industrial (INPI). (2023). Patent information on AR107891. Argentina: INPI.
- World Intellectual Property Organization. (2022). Patent landscape reports Latin America. WIPO.
- Argentina Patent Law. (1996). Law No. 24,481, and related amendments.
- Prior Art Database. (2022). Patent document comparison and analysis.
- Latin American Patent Office Reports. (2022). Regional patent activity.
[1] Instituto Nacional de la Propiedad Industrial (INPI). (2023). Patent AR107891.
